Novartis AG is 97.0x more valuable than Arcutis Biotherapeutics, Inc. by market capitalization ($283.13 B vs $2.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARQT | NVS |
|---|---|---|
| Market cap | $2.92 B | $283.13 B |
| US-listed rank | #1826 | #47 |
| Revenue (latest FY) | $376.07M | - |
| Net income (latest FY) | -$16.14M | - |
| Net margin | -4.3% | - |
| SEC filings | 798 | 947 |
Novartis AG is 97.0x more valuable than Arcutis Biotherapeutics, Inc. by market capitalization ($283.13 B vs $2.92 B).
Full pages: Arcutis Biotherapeutics, Inc. and Novartis AG, or browse the full rankings.